Medicare Enrolled

Dr. Brian Burlew, MD

Pulmonary Disease · Bethlehem, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
5325 NORTHGATE DRIVE, Bethlehem, PA 18017
6106258898
In practice since 2006 (20 years)
NPI: 1598712119 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Burlew from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burlew? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Burlew

Dr. Brian Burlew is a pulmonary disease specialist in Bethlehem, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Burlew performed 2,431 Medicare services across 1,461 unique beneficiaries.

Between the years covered by Open Payments, Dr. Burlew received a total of $107,883 from 30 pharmaceutical and/or device companies across 394 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Burlew is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 6% volume in PA $107,883 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,431
Medicare services
Top 6% in PA for pulmonary disease
1,461
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~122 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
538 $63 $147
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
487 $60 $172
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
436 $92 $212
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
386 $38 $155
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
97 $124 $316
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
83 $7 $75
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
79 $98 $270
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
68 $89 $210
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
55 $11 $30
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
41 $6 $145
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
39 $129 $391
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
36 $9 $150
Lung cancer screening counseling visit
A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making.
32 $28 $60
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $116 $286
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
20 $58 $180
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
14 $65 $195
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$107,883
Total received (2018-2024)
Avg $15,412/year across 7 years
Top 4% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
394
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$103,709 (96.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,175 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,145
2023
$10,971
2022
$8,446
2021
$15,960
2020
$10,997
2019
$22,394
2018
$33,970

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,941
AstraZeneca Pharmaceuticals LP
$204
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$79,306
AstraZeneca Pharmaceuticals LP
$16,550
Sunovion Pharmaceuticals Inc.
$8,385
GlaxoSmithKline, LLC.
$1,489
United Therapeutics Corporation
$432
Actelion Pharmaceuticals US, Inc.
$267
Regeneron Healthcare Solutions, Inc.
$188
E.R. Squibb & Sons, L.L.C.
$132
GENZYME CORPORATION
$127
Takeda Pharmaceuticals U.S.A., Inc.
$92
Harmony Biosciences LLC
$86
HARMONY BIOSCIENCES LLC
$85
Grifols USA, LLC
$83
Philips Electronics North America Corporation
$65
Paratek Pharmaceuticals, Inc.
$64
JAZZ PHARMACEUTICALS INC.
$64
Genentech USA, Inc.
$64
Advanced Respiratory, Inc
$63
Baxter Healthcare
$55
Ambu Inc.
$54
Mylan Specialty L.P.
$30
Pharming Healthcare, Inc.
$28
Amgen Inc.
$27
Inspire Medical Systems, Inc.
$23
Shire North American Group Inc
$23
Merck Sharp & Dohme LLC
$22
Alexion Pharmaceuticals, Inc.
$22
Circassia Pharmaceuticals Inc
$20
Vapotherm Inc
$19
Phadia US Inc.
$17
Top 3 companies account for 96.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · DALIRESP · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Volara System · INSPIRE · ImmunoCAP · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · Prolastin-C Liquid · REMODULIN · RUCONEST · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · ULTOMIRIS · Utibron · VAPOTHERM · WAKIX · Wakix · XYWAV · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pulmonary disease in PA.

Looking for a pulmonary disease specialist in Bethlehem?
Compare pulmonary diseases in the Bethlehem area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
39
Per 100K population
12.3
County median income
$86,687
Nearest hospital
ST LUKES HOSPITAL BETHLEHEM
5.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Burlew is a clinical cardiology specialist, with above-average Medicare volume (top 6% in PA), with speaking/promotional industry engagement in the top 4% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Burlew experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Burlew performed 538 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Burlew receive payments from pharmaceutical companies?
Yes. Dr. Burlew received a total of $107,883 from 30 companies across 394 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burlew's costs compare to other pulmonary diseases in Bethlehem?
Dr. Burlew's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burlew) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →